Delivery Order SPE2DB22D2206-SPE2DB25FKE62
- Not listed
- The Defense Logistics Agency awarded a $14,687.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Imdelltra 10 mg vials, with a completion date of June 9, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,034.66 to AmerisourceBergen Drug Corp for the supply of IMDELLTRA 1 MG vials. The contract is firm fixed price with an ultimate completion date of August 15, 2025, and represents a non-competitive, competitively awarded procurement. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $10,329.44 to AmerisourceBergen Drug Corp for Imdelltra 10 mg vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $2,167.54 to AmerisourceBergen Drug Corp on September 8, 2025, for pharmaceutical products under a firm fixed-price contract. This competitively awarded delivery order, with an ultimate completion date of September 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,579.10 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a non-set-aside award, reflecting the contractor's...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $53,227.77 on May 22, 2025, with a completion date of the same day. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,301.16 to AmerisourceBergen Drug Corp on September 18, 2025, for pharmaceutical products and medical supplies. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is set to be completed by September 19, 2025, and will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, with a ceiling value of $2,343.59. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $808,676.97 to AmerisourceBergen Drug Corp on September 6, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, issued without a set-aside designation, is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,724.96 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA and carries no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKE62Delivery Order
The Defense Logistics Agency awarded a $2,069.32 delivery order to AmerisourceBergen Drug Corp for Imdelltra 1 mg vials, a pharmaceutical product supporting federal medical procurement needs. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of October 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen holds extensive experience fulfilling complex medical supply requirements across multiple therapeutic domains through competitively awarded contracts with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/29/25 |